About Transcure Therapeutics Private Limited
Data last updated:
Transcure Therapeutics Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230PB2005PTC029115. Its GSTIN is 03AAKCS1723R1Z1 (Punjab). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Sefcare Chemicals Private Limited. It is led by directors Davinder Vijay Garg and Vivek Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 970/B/1 1st Floor New Vivek Nagar Dhobi Ghat Chowk, Ludhiana, Punjab, India – 141001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.85 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹8.1 Lakh (net margin 1.7%) and EBITDA of ₹32.86 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 29% over five years.
As per MCA filings, the company has open charges of ₹41 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website transcure.in.
Company details
Contact details
Transcure Therapeutics Private Limited's registered office is in Ludhiana, Punjab. Its website is transcure.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address970/B/1 1st Floor New Vivek Nagar Dhobi Ghat Chowk, Ludhiana, Punjab, India – 141001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Transcure Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Transcure Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Transcure Therapeutics Private Limited, buy the company report.
Financials of Transcure Therapeutics Private Limited
FY 2025 filings availableTranscure Therapeutics Private Limited reported revenue of ₹4.85 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 17% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Transcure Therapeutics Private Limited, buy the company report.
Board of directors of Transcure Therapeutics Private Limited
Transcure Therapeutics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Davinder Vijay Garg | Director | 28 Oct 2008 | 18 Years 0 Months | Current |
| Vivek Srivastava | Director | 23 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Transcure Therapeutics Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allen's India Ltd. | ₹4.86 Cr (FY 2024) | 1.0% | Kolkata, West Bengal, India | |||
| Uniphar Biotech Private Limited | ₹4.85 Cr (FY 2024) | -9.0% | Chandigarh, India | |||
| Villmed Laboratories Private Limited | ₹4.85 Cr (FY 2024) | 112.0% | Selaqui, Uttarakhand, India | |||
| Transcure Therapeutics Private Limitedthis company | ₹4.85 Cr (FY 2025) | ₹8.1 Lakh | 1.7% | 17.0% | Ludhiana, Punjab, India | |
| Exhar Formulations Private Limited | ₹4.84 Cr (FY 2020) | 21.0% | New Delhi, Delhi, India | |||
| Sycon Healthcare Private Limited | ₹4.83 Cr (FY 2024) | 0.0% | Shahabad Markanda, Haryana, India | |||
| VRD Pharmaceuticals and Surgicals Private Limited | ₹4.83 Cr (FY 2024) | -20.0% | Dibrugarh, Assam, India |
To see the full peer comparison of Transcure Therapeutics Private Limited, buy the company report.
Auditor
Transcure Therapeutics Private Limited is audited by ANKUSH GARG & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKUSH GARG & ASSOCIATES | FY 2022 | 023910N |
Shareholding
The shareholding of Transcure Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Transcure Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2024 | 100924275 | Others | ₹16 Lakh | Open | |
| 09 May 2024 | 100918268 | Others | ₹15 Lakh | Open | |
| 10 Oct 2023 | 100805179 | Others | ₹10 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Transcure Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Transcure Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Transcure Therapeutics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAKCS1723R1Z1 | Punjab | Active | 01 Jul 2017 |
| 02AAKCS1723R1Z3 | Himachal Pradesh | Active | 21 Aug 2022 |
To see the full GST registrations and return filing status of Transcure Therapeutics Private Limited, buy the company report.
Recent activity
Transcure Therapeutics Private Limited has 5 board changes on record since 2008: 2 appointments and 3 cessations. The latest: Asha Garg ceased to be Director on 23 Jan 2017.
Frequently asked questions
Transcure Therapeutics is an active private limited company based in Ludhiana, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 October 2005 (21+ years old) and is registered under CIN U24230PB2005PTC029115.
Transcure Therapeutics has 2 current directors:
- Davinder Vijay Garg - Director
- Vivek Srivastava - Director
The latest financial statements of Transcure Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Transcure Therapeutics is 03AAKCS1723R1Z1, registered in Punjab. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAKCS1723R1Z3 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Transcure Therapeutics is U24230PB2005PTC029115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Transcure Therapeutics was incorporated on 24 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Transcure Therapeutics by revenue are Allen's India Ltd, Uniphar Biotech Private Limited, Villmed Laboratories Private Limited, Exhar Formulations Private Limited, Sycon Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Asha Garg ceased to be Director on 23 Jan 2017. Harpreet Singh ceased to be Director on 23 Jan 2017. Vivek Srivastava was appointed as Director on 23 Jan 2017. Transcure Therapeutics has 5 board changes on record in total.
Transcure Therapeutics can be reached through the website transcure.in. Its registered office is in Ludhiana, Punjab, India.
The registered office of Transcure Therapeutics is at 970B1 1st Floor New Vivek Nagar Dhobi Ghat Chowk, Ludhiana, Punjab, India – 141001.
Transcure Therapeutics operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
